We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials.
- Authors
Oellers, Patrick; Grewal, Dilraj S.; Fekrat, Sharon
- Abstract
For years, the standard of care for branch-retinal-vein-occlusion-associated macular edema was initial observation followed by grid-pattern laser photocoagulation for persistent edema. Newer pharmacologic options have revolutionized the management of branch-retinal-vein-occlusion-associated macular edema, and the visual outcomes of these eyes are better than ever. However, a variety of available treatment options including intravitreal corticosteroids and intravitreal antivascular endothelial growth factor agents have established novel challenges with regard to appropriate drug selection. This review summarizes the available clinical studies with special emphasis on the comparison of intravitreal aflibercept with ranibizumab, bevacizumab, and steroid agents.
- Subjects
DRUG therapy; EDEMA; METABOLIC disorder treatment; RETINAL vein occlusion; CLINICAL trials; LASER photocoagulation; ADRENOCORTICAL hormones; VASCULAR endothelial growth factors
- Publication
Clinical Ophthalmology, 2016, Vol 10, p411
- ISSN
1177-5467
- Publication type
Article
- DOI
10.2147/OPTH.S98853